Acrolein scavengers: Reactivity, mechanism and impact on health

Molecular Nutrition and Food Research

Volumn 55, Issue 9, 2011, Pages 1375-1390

  Zhu, Qin ^a   Sun, Zheng ^a   Jiang, Yue ^b   Chen, Feng ^a,c   Wang, Mingfu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c PEKING UNIVERSITY   (China)

Author keywords

Acrolein; Antioxidants; Lipid peroxidation; Scavengers

Indexed keywords

EID: 80052525395     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100149     Document Type: Review

References (136)

1. Faroon, O., Roney, N., Taylor, J., Ashizawa, A. et al., Acrolein health effects. Toxicol. Ind. Health 2008, 24, 447-490.
2. Beauchamp, R. O., Jr., Andjelkovich, D. A., Kligerman, A. D., Morgan, K. T., Heck, H. D., A critical review of the literature on acrolein toxicity. Crit. Rev. Toxicol. 1985, 14, 309-380.
3. Faroon, O., Roney, N., Taylor, J., Ashizawa, A. et al., Acrolein environmental levels and potential for human exposure. Toxicol. Ind. Health 2008, 24, 543-564.
4. Umano, K., Shibamoto, T., Analysis of acrolein from heated cooking oils and beef fat. J. Agric. Food Chem. 1987, 35, 909-912.
5. O'Brien, P. J., Siraki, A. G., Shangari, N., Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit. Rev. Toxicol. 2005, 35, 609-662.
6. Cannon, J., Linke, C. A., Cos, L. R., Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention. Urology 1991, 38, 413-416.
7. Pan, X. Q., Kaneko, H., Ushio, H., Ohshima, T., Oxidation of all-cis-7, 10, 13, 16, 19-docosapentaenoic acid ethyl ester. Hydroperoxide distribution and volatile characterization. Eur. J. Lipid Sci. Technol. 2005, 107, 228-238.
8. Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T. et al., Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 1998, 273, 16058-16066.
9. Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T. et al., Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. USA 1998, 95, 4882-4887.
10. Uchida, K., Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc. Med. 1999, 9, 109-113.
11. Burcham, P. C., Kaminskas, L. M., Tan, D., Pyke, S. M., Carbonyl-scavenging drugs and protection against carbonyl stress-associated cell injury. Mini Rev. Med. Chem. 2008, 8, 319-330.
12. Stevens, J. F., Maier, C. S., Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 2008, 52, 7-25.
13. Witz, G., Biological interactions of alpha, beta-unsaturated aldehydes. Free Radic. Biol. Med. 1989, 7, 333-349.
14. Calingasan, N. Y., Uchida, K., Gibson, G. E., Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J. Neurochem. 1999, 72, 751-756.
15. Burcham, P. C., Fontaine, F. R., Kaminskas, L. M., Petersen, D. R., Pyke, S. M., Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity. Mol. Pharm. 2004, 65, 655-664.
16. 2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res. 1984, 44, 990-995.
17. Stone, M. P., Cho, Y. J., Huang, H., Kim, H. Y. et al., Interstrand DNA cross-links induced by alpha, beta-unsaturated aldehydes derived from lipid peroxidation and environmental sources. Acc. Chem. Res. 2008, 41, 793-804.
18. Chung, F. L., Chen, H. J. C., Nath, R. G., Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis 1996, 17, 2105-2111.
19. 2-propanodeoxyguanosine adducts. Mutat. Res. 1999, 424, 71-81.
20. Dickinson, D. A., Forman, H. J., Cellular glutathione and thiols metabolism. Biochem. Pharmacol. 2002, 64, 1019-1026.
21. Esterbauer, H., Schaur, R. J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11, 81-128.
22. Kehrer, J. P., Biswal, S. S., The molecular effects of acrolein. Toxicol. Sci. 2000, 57, 6-15.
23. Grafstrom, R. C., Dypbukt, J. M., Willey, J. C., Sundqvist, K. et al., Pathobiological effects of acrolein in cultured human bronchial epithelial cells. Cancer Res. 1988, 48, 1717-1721.
24. Ellis, E. M., Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol. Ther. 2007, 115, 13-24.
25. Lovell, M. A., Xie, C., Markesbery, W. R., Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 2001, 22, 187-194.
26. Hamann, K., Shi, R., Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury. J. Neurochem. 2009, 111, 1348-1356.
27. Yong, P. H., Zong, H., Medina, R. J., Limb, G. A. et al., Evidence supporting a role for N-(3-formyl-3, 4-dehydropiperidino)lysine accumulation in Muller glia dysfunction and death in diabetic retinopathy. Mol. Vis. 2010, 16, 2524-2538.
28. LoPachin, R. M., Barber, D. S., Gavin, T., Molecular mechanisms of the conjugated alpha, beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases. Toxicol. Sci. 2008, 104, 235-249.
29. Zeng, J. M., Davies, M. J., Protein and low molecular mass thiols as targets and inhihitors of glycation reactions. Chem. Res. Toxicol. 2006, 19, 1668-1676.
30. Dalle-Donne, I., Carini, M., Vistoli, G., Gamberoni, L. et al., Actin Cys374 as a nucleophilic target of alpha, beta-unsaturated aldehydes. Free Radic. Biol. Med. 2007, 42, 583-598.
31. Esterbauer, H., Zollner, H., Scholz, N., Reaction of glutathione with conjugated carbonyls. Z. Naturforsch. C 1975, 30, 466-473.
32. Esterbauer, H., Ertl, A., Scholz, N., Reaction of cysteine with alpha, beta-unsaturated aldehydes. Tetrahedron 1976, 32, 285-289.
33. Wlodek, L., The reaction of sulfhydryl groups with carbonyl compounds. Acta Biochim. Pol. 1988, 35, 307-317.
34. Takamoto, S., Sakura, N., Yashiki, M., Kojima, T., Inactivation of acrolein by sodium 2-mercaptoethanesulfonate using headspace-solid-phase microextraction gas chromatography and mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 791, 365-369.
35. Kaminskas, L. M., Pyke, S. M., Burcham, P. C., Reactivity of hydrazinophthalazine drugs with the lipid peroxidation products acrolein and crotonaldehyde. Org. Biomol. Chem. 2004, 2, 2578-2584.
36. Pocernich, C. B., Butterfield, D. A., Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox. Res. 2003, 5, 515-520.
37. Qing, W. G., Powell, K. L., MacLeod, M. C., Kinetics of the reaction of a potential chemopreventive agent, 2, 6-dithiopurine, and its major metabolite, 2, 6-dithiouric acid, with multiple classes of electrophilic toxicants. Chem. Res. Toxicol. 1996, 9, 1298-1304.
38. Cai, J., Bhatnagar, A., Pierce, W. M., Jr., Protein modification by acrolein: formation and stability of cysteine adducts. Chem. Res. Toxicol. 2009, 22, 708-716.
39. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D. et al., Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44-84.
40. Pastore, A., Federici, G., Bertini, E., Piemonte, F., Analysis of glutathione: implication in redox and detoxification. Clin. Chim. Acta 2003, 333, 19-39.
41. Mitchell, D. Y., Petersen, D. R., Metabolism of the glutathione-acrolein adduct, S-(2-aldehydo-ethyl)glutathione, by rat liver alcohol and aldehyde dehydrogenase. J. Pharmacol. Exp. Ther. 1989, 251, 193-198.
42. 14C]acrolein in Sprague-Dawley rats: II. Identification of urinary and fecal metabolites. Toxicol. Sci. 1998, 43, 110-120.
43. Carmella, S. G., Chen, M. L., Zhang, Y., Zhang, S. Y. et al., Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem. Res. Toxicol. 2007, 20, 986-990.
44. Marinello, A. J., Bansal, S. K., Paul, B., Koser, P. L. et al., Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450. Cancer Res. 1984, 44, 4615-4621.
45. Nunoshiba, T., Yamamoto, K., Role of glutathione on acrolein-induced cytotoxicity and mutagenicity in Escherichia coli. Mutat. Res. 1999, 442, 1-8.
46. He, N. G., Awasthi, S., Singhal, S. S., Trent, M. B., Boor, P. J., The role of glutathione S-transferases as a defense against reactive electrophiles in the blood vessel wall. Toxicol. Appl. Pharm. 1998, 152, 83-89.
47. Yang, Y., Trent, M. B., He, N., Lick, S. D. et al., Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: possible role in human atherosclerosis. Atherosclerosis 2004, 173, 211-221.
48. Witschi, A., Reddy, S., Stofer, B., Lauterburg, B. H., The systemic availability of oral glutathione. Eur. J. Clin. Pharmacol. 1992, 43, 667-669.
49. Pocernich, C. B., La Fontaine, M., Butterfield, D. A., In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochem. Int. 2000, 36, 185-191.
50. Gillissen, A., Jaworska, M., Orth, M., Coffiner, M. et al., Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Resp. Med. 1997, 91, 159-168.
51. Gross, C. L., Innace, J. K., Hovatter, R. C., Meier, H. L., Smith, W. J., Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard. Cell Biol. Toxicol. 1993, 9, 259-267.
52. Meister, A., Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 1991, 51, 155-194.
53. Gugliucci, A., Lunceford, N., Kinugasa, E., Ogata, H. et al., Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Clin. Chim. Acta 2007, 384, 105-112.
54. Gugliucci, A., Antithrombin activity is inhibited by acrolein and homocysteine thiolactone: protection by cysteine. Life Sci. 2008, 82, 413-418.
55. Yoshida, M., Tomitori, H., Machi, Y., Hagihara, M. et al., Acrolein toxicity: comparison with reactive oxygen species. Biochem. Biophys. Res. Commun. 2009, 378, 313-318.
56. Tanel, A., Averill-Bates, D. A., Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteine. J. Pharmacol. Exp. Ther. 2007, 321, 73-83.
57. Thanh Nam, D., Arseneault, M., Zarkovic, N., Waeg, G., Ramassamy, C., Molecular regulations induced by acrolein in neuroblastoma SK-N-SH cells: relevance to Alzheimer's disease. J. Alzheimers Dis. 2010.
58. Yang, Q., Hergenhahn, M., Weninger, A., Bartsch, H., Cigarette smoke induces direct DNA damage in the human B-lymphoid cell line Raji. Carcinogenesis 1999, 20, 1769-1775.
59. Caito, S., Rajendrasozhan, S., Cook, S., Chung, S. et al., SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J. 2010, 24, 3145-3159.
60. Moretto, N., Facchinetti, F., Southworth, T., Civelli, M. et al., alpha, beta-unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 296, L839-L848.
61. O'Toole, T. E., Zheng, Y. T., Hellmann, J., Conklin, D. J. et al., Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages. Toxicol. Appl. Pharmacol. 2009, 236, 194-201.
62. Szadkowski, A., Myers, C. R., Acrolein oxidizes the cytosolic and mitochondrial thioredoxins in human endothelial cells. Toxicology 2008, 243, 164-176.
63. Critchley, J. A., Beeley, J. M., Clark, R. J., Summerfield, M. et al., Evaluation of N-acetylcysteine and methylprednisolone as therapies for oxygen and acrolein-induced lung damage. Environ. Health Perspect. 1990, 85, 89-94.
64. Takamoto, S., Sakura, N., Namera, A., Yashiki, M., Monitoring of urinary acrolein concentration in patients receiving cyclophosphamide and ifosphamide. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 806, 59-63.
65. Kawabata, T. T., Chapman, M. Y., Kim, D. H., Stevens, W. D., Holsapple, M. P., Mechanisms of in vitro immunosuppression by hepatocyte-generated cyclophosphamide metabolites and 4-hydroperoxycyclophosphamide. Biochem. Pharmacol. 1990, 40, 927-935.
66. Zaki, E. L., Springate, J. E., Taub, M., Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells. Toxicol. In Vitro 2003, 17, 397-402.
67. Ghaida, J., Merker, H. J., Effects of cyclophosphamide and acrolein in organoid cultures of mouse limb bud cells grown in the presence of adult rat hepatocytes. Toxicol. In Vitro 1992, 6, 27-40.
68. Batista, C. K., Brito, G. A., Souza, M. L., Leitao, B. T. et al., A model of hemorrhagic cystitis induced with acrolein in mice. Braz. J. Med. Biol. Res. 2006, 39, 1475-1481.
69. Goren, M. P., Houle, J. M., Bush, D. A., Li, J. T. et al., Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects. Clin. Cancer Res. 1998, 4, 2313-2320.
70. Mohrmann, M., Ansorge, S., Schonfeld, B., Brandis, M., Dithio-bis-mercaptoethanesulphonate (DIMESNA) does not prevent cellular damage by metabolites of ifosfamide and cyclophosphamide in LLC-PK1 cells. Pediatr. Nephrol. 1994, 8, 458-465.
71. Smith, A. R., Shenvi, S. V., Widlansky, M., Suh, J. H., Hagen, T. M., Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr. Med. Chem. 2004, 11, 1135-1146.
72. Jomova, K., Vondrakova, D., Lawson, M., Valko, M., Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 2010, 345, 91-104.
73. Jia, Z., Hallur, S., Zhu, H., Li, Y., Misra, H. P., Potent upregulation of glutathione and NAD(P)H:quinone oxidoreductase 1 by alpha-lipoic acid in human neuroblastoma SH-SY5Y cells: protection against neurotoxicant-elicited cytotoxicity. Neurochem. Res. 2008, 33, 790-800.
74. Jia, L., Zhang, Z., Zhai, L., Bai, Y., Protective effect of lipoic acid against acrolein-induced cytotoxicity in IMR-90 human fibroblasts. J. Nutr. Sci. Vitaminol. (Tokyo) 2009, 55, 126-130.
75. Suh, J. H., Wang, H., Liu, R. M., Liu, J., Hagen, T. M., (R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis. Arch. Biochem. Biophys. 2004, 423, 126-135.
76. Nath, R. G., Wu, M. Y., Emami, A., Chung, F. L., Effects of epigallocatechin gallate, L-ascorbic acid, alpha-tocopherol, and dihydrolipoic acid on the formation of deoxyguanosine adducts derived from lipid peroxidation. Nutr. Cancer 2010, 62, 622-629.
77. Li, X., Liu, Z., Luo, C., Jia, H. et al., Lipoamide protects retinal pigment epithelial cells from oxidative stress and mitochondrial dysfunction. Free Radic. Biol. Med. 2008, 44, 1465-1474.
78. Datta, K., Chin, A., Ahmed, T., Qing, W. G. et al., Mixed effects of 2, 6-dithiopurine against cyclophosphamide mediated bladder and lung toxicity in mice. Toxicology 1998, 125, 1-11.
79. Kensler, T. W., Curphey, T. J., Maxiutenko, Y., Roebuck, B. D., Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins. Drug Metabol. Drug Interact. 2000, 17, 3-22.
80. Cao, Z., Hardej, D., Trombetta, L. D., Trush, M. A., Li, Y., Induction of cellular glutathione and glutathione S-transferase by 3H-1, 2-dithiole-3-thione in rat aortic smooth muscle A10 cells: protection against acrolein-induced toxicity. Atherosclerosis 2003, 166, 291-301.
81. Jia, Z., Misra, B. R., Zhu, H., Li, Y., Misra, H. P., Upregulation of cellular glutathione by 3H-1, 2-dithiole-3-thione as a possible treatment strategy for protecting against acrolein-induced neurocytotoxicity. Neurotoxicology 2009, 30, 1-9.
82. Zhu, H., Jia, Z., Strobl, J. S., Ehrich, M. et al., Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress. Cardiovasc. Toxicol. 2008, 8, 115-125.
83. Kelleher, M. O., McMahon, M., Eggleston, I. M., Dixon, M. J. et al., 1-Cyano-2, 3-epithiopropane is a novel plant-derived chemopreventive agent which induces cytoprotective genes that afford resistance against the genotoxic alpha, beta-unsaturated aldehyde acrolein. Carcinogenesis 2009, 30, 1754-1762.
84. Burcham, P. C., Kerr, P. G., Fontaine, F., The antihypertensive hydralazine is an efficient scavenger of acrolein. Redox Rep. 2000, 5, 47-49.
85. Carini, M., Aldini, G., Beretta, G., Arlandini, E., Facino, R. M., Acrolein-sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine/acrolein adducts by electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 2003, 38, 996-1006.
86. Burcham, P. C., Kaminskas, L. M., Fontaine, F. R., Petersen, D. R., Pyke, S. M., Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products. Toxicology 2002, 181, 229-236.
87. Aldini, G., Vistoli, G., Regazzoni, L., Benfatto, M. C. et al., Edaravone inhibits protein carbonylation by a direct carbonyl-scavenging mechanism: focus on reactivity, selectivity, and reaction mechanisms. Antioxid. Redox Signal. 2010, 12, 381-392.
88. Beretta, G., Arlandini, E., Artali, R., Anton, J. M. G., Facino, R. M., Acrolein sequestering ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK): characterization of conjugation products by ESI-MSn and theoretical calculations. J. Pharm. Biomed. Anal. 2008, 47, 596-602.
89. Tuncel, M., Ram, V. C., Hypertensive emergencies. Etiology and management. Am. J. Cardiovasc. Drugs 2003, 3, 21-31.
90. O'Donnell, J. P., The reaction of amines with carbonyls: its significance in the nonenzymatic metabolism of xenobiotics. Drug Metab. Rev. 1982, 13, 123-159.
91. Burcham, P. C., Pyke, S. M., Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection. Mol. Pharmacol. 2006, 69, 1056-1065.
92. Liu-Snyder, P., Borgens, R. B., Shi, R., Hydralazine rescues PC12 cells from acrolein-mediated death. J. Neurosci. Res. 2006, 84, 219-227.
93. Nelson, T. J., Boor, P. J., Allylamine cardiotoxicity - IV. Metabolism to acrolein by cardiovascular tissues. Biochem. Pharmacol. 1982, 31, 509-514.
94. Hamann, K., Durkes, A., Ouyang, H., Uchida, K. et al., Critical role of acrolein in secondary injury following ex vivo spinal cord trauma. J. Neurochem. 2008, 107, 712-721.
95. Kaminskas, L. M., Pyke, S. M., Burcham, P. C., Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice. J. Pharmacol. Exp. Ther. 2004, 310, 1003-1010.
96. Leung, G., Sun, W., Zheng, L., Brookes, S. et al., Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune encephalomyelitis mouse. Neuroscience 2011, 173, 150-155.
97. Galvani, S., Coatrieux, C., Elbaz, M., Grazide, M. H. et al., Carbonyl scavenger and antiatherogenic effects of hydrazine derivatives. Free Radic. Biol. Med. 2008, 45, 1457-1467.
98. Bonfanti, L., Peretto, P., De Marchis, S., Fasolo, A., Carnosine-related dipeptides in the mammalian brain. Prog. Neurobiol. 1999, 59, 333-353.
99. Babizhayev, M. A., Seguin, M. C., Gueyne, J., Evstigneeva, R. P. et al., L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities. Biochem. J. 1994, 304, 509-516.
100. Chan, K. M., Decker, E. A., Endogenous skeletal muscle antioxidants. Crit. Rev. Food Sci. Nutr. 1994, 34, 403-426.
101. Price, D. L., Rhett, P. M., Thorpe, S. R., Baynes, J. W., Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem. 2001, 276, 48967-48972.
102. Quinn, P. J., Boldyrev, A. A., Formazuyk, V. E., Carnosine: its properties, functions and potential therapeutic applications. Mol. Aspects Med. 1992, 13, 379-444.
103. Mcfarland, G. A., Holliday, R., Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp. Cell Res. 1994, 212, 167-175.
104. Seidler, N. W., Kowalewski, C., Methylglyoxal-induced glycation affects protein topography. Arch. Biochem. Biophys. 2003, 410, 149-154.
105. Seidler, N. W., Yeargans, G. S., Morgan, T. G., Carnosine disaggregates glycated alpha-crystallin: an in vitro study. Arch. Biochem. Biophys. 2004, 427, 110-115.
106. Hipkiss, A. R., Preston, J. E., Himsworth, D. T., Worthington, V. C. et al., Pluripotent protective effects of carnosine, a naturally occurring dipeptide. Ann. N Y Acad. Sci. 1998, 854, 37-53.
107. Kang, J. H., Protection by histidine dipeptides against acrolein-induced neurofilament-L aggregation. Bull. Korean Chem. Soc. 2008, 29, 1732-1736.
108. Thornalley, P. J., Yurek-George, A., Argirov, O. K., Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions. Biochem. Pharmacol. 2000, 60, 55-65.
109. Jakus, V., Rietbrock, N., Advanced glycation end-products and the progress of diabetic vascular complications. Physiol. Res. 2004, 53, 131-142.
110. Adrover, M., Vilanova, B., Frau, J., Munoz, F., Donoso, J., The pyridoxamine action on Amadori compounds: a reexamination of its scavenging capacity and chelating effect. Bioorg. Med. Chem. 2008, 16, 5557-5569.
111. Voziyan, P. A., Metz, T. O., Baynes, J. W., Hudson, B. G., A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J. Biol. Chem. 2002, 277, 3397-3403.
112. Metz, T. O., Alderson, N. L., Thorpe, S. R., Baynes, J. W., Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. Arch. Biochem. Biophys. 2003, 419, 41-49.
113. Metz, T. O., Alderson, N. L., Chachich, M. E., Thorpe, S. R., Baynes, J. W., Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo. Evidence on the role of lipids in chemical modification of protein and development of diabetic complications. J. Biol. Chem. 2003, 278, 42012-42019.
114. Aldini, G., Dalle-Donne, I., Facino, R. M., Milzani, A., Carini, M., Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med. Res. Rev. 2007, 27, 817-868.
115. Shao, X., Bai, N., He, K., Ho, C. T. et al., Apple polyphenols, phloretin and phloridzin: new trapping agents of reactive dicarbonyl species. Chem. Res. Toxicol. 2008, 21, 2042-2050.
116. Sang, S., Shao, X., Bai, N., Lo, C. Y. et al., Tea Polyphenol (-)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species. Chem. Res. Toxicol. 2007, 20, 1862-1870.
117. Lo, C. Y., Li, S. M., Tan, D., Pan, M. H. et al., Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions. Mol. Nutr. Food Res. 2006, 50, 1118-1128.
118. Beretta, G., Furlanetto, S., Regazzoni, L., Zarrella, M., Facino, R. M., Quenching of alpha, beta-unsaturated aldehydes by green tea polyphenols: HPLC-ESI-MS/MS studies. J. Pharm. Biomed. Anal. 2008, 48, 606-611.
119. Zhu, Q., Liang, C. P., Cheng, K. W., Peng, X. et al., Trapping effects of green and black tea extracts on peroxidation-derived carbonyl substances of seal blubber oil. J. Agric. Food Chem. 2009, 57, 1065-1069.
120. Zhu, Q., Zheng, Z. P., Cheng, K. W., Wu, J. J. et al., Natural polyphenols as direct trapping agents of lipid peroxidation-derived acrolein and 4-hydroxy-trans-2-nonenal. Chem. Res. Toxicol. 2009, 22, 1721-1727.
121. Bravo, L., Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 1998, 56, 317-333.
122. Ansari, M. A., Keller, J. N., Scheff, S. W., Protective effect of pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity. Free Radic. Biol. Med. 2008, 45, 1510-1519.
123. Singh, M., Murthy, V., Ramassamy, C., Modulation of hydrogen peroxide and acrolein-induced oxidative stress, mitochondrial dysfunctions and redox regulated pathways by the Bacopa monniera extract: potential implication in Alzheimer's disease. J. Alzheimers Dis. 2010, 21, 229-247.
124. Zhang, X. W., Li, W. F., Li, W. W., Ren, K. H. et al., Protective effects of the aqueous extract of Scutellaria baicalensis against acrolein-induced oxidative stress in cultured human umbilical vein endothelial cells. Pharm. Biol. 2011, 49, 256-261.
125. Yang, C. H., Lin, C. Y., Yang, J. H., Liou, S. Y. et al., Supplementary catechins attenuate cooking-oil-fumes-induced oxidative stress in rat lung. Chin. J. Physiol. 2009, 52, 151-159.
126. Huang, W., Niu, H., Xue, X., Li, J., Li, C., Robinetinidol-(4beta-->8)-epigallocatechin 3-O-gallate, a galloyl dimer prorobinetinidin from Acacia Mearnsii De Wild, effectively protects human neuroblastoma SH-SY5Y cells against acrolein-induced oxidative damage. J. Alzheimers Dis. 2010, 21, 493-506.
127. Sheu, S. J., Liu, N. C., Chen, J. L., Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage. J. Ocul. Pharmacol. Ther. 2010, 26, 231-236.
128. Liu, Z., Sun, L., Zhu, L., Jia, X. et al., Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction. J. Neurochem. 2007, 103, 2690-2700.
129. Scalbert, A., Manach, C., Morand, C., Remesy, C., Jimenez, L., Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 2005, 45, 287-306.
130. Fodor, G., Arnold, R., Mohacsi, T., Karle, I., Flippenanderson, J., A new role for L-ascorbic acid: Michael donor to alpha, beta-unsaturated carbonyl-compounds. Tetrahedron 1983, 39, 2137-2145.
131. Kesinger, N. G., Langsdorf, B. L., Yokochi, A. F., Miranda, C. L., Stevens, J. F., Formation of a vitamin C conjugate of acrolein and its paraoxonase-mediated conversion into 5, 6, 7, 8-tetrahydroxy-4-oxooctanal. Chem. Res. Toxicol. 2010, 23, 836-844.
132. Bergsten, P., Amitai, G., Kehrl, J., Dhariwal, K. R. et al., Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes. Depletion and reaccumulation. J. Biol. Chem. 1990, 265, 2584-2587.
133. Arai, H., Uchida, K., Nakamura, K., Effect of ascorbate on acrolein modification of very low density lipoprotein and uptake of oxidized apolipoprotein E by hepatocytes. Biosci. Biotechnol. Biochem. 2005, 69, 1760-1762.
134. Logan, M. P., Parker, S., Shi, R., Glutathione and ascorbic acid enhance recovery of Guinea pig spinal cord white matter following ischemia and acrolein exposure. Pathobiology 2005, 72, 171-178.
135. Nardini, M., Finkelstein, E. I., Reddy, S., Valacchi, G. et al., Acrolein-induced cytotoxicity in cultured human bronchial epithelial cells. Modulation by alpha-tocopherol and ascorbic acid. Toxicology 2002, 170, 173-185.
136. Singh, M., Nam, D. T., Arseneault, M., Ramassamy, C., Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein. J. Alzheimers Dis. 2010, 21, 741-756.